Palisades Hudson Asset Management, L.P. Amgen Inc Transaction History
Palisades Hudson Asset Management, L.P.
- $237 Million
- Q3 2024
A detailed history of Palisades Hudson Asset Management, L.P. transactions in Amgen Inc stock. As of the latest transaction made, Palisades Hudson Asset Management, L.P. holds 758 shares of AMGN stock, worth $197,982. This represents 0.1% of its overall portfolio holdings.
Number of Shares
758
Previous 662
14.5%
Holding current value
$197,982
Previous $207,000
17.87%
% of portfolio
0.1%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding AMGN
# of Institutions
3,125Shares Held
409MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$13.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$7.66 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$3.84 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.72 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $140B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...